Positive Topline Data for Sotatercept in PAH: STELLAR Positive Topline Data for Sotatercept in PAH: STELLAR

Sotatercept added to standard therapy led to improves exercise capacity in adults with pulmonary arterial hypertension in a phase 3 trial. Merck plans to file for US regulatory approval.Medscape Medical News

Source: Medscape Critical Care Headlines - October 13, 2022 Category: Intensive Care Tags: Cardiology News Source Type: news